Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 022404
Company: GALT PHARMS
Company: GALT PHARMS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
ORAVIG | MICONAZOLE | 50MG | TABLET;BUCCAL | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
04/16/2010 | ORIG-1 | Approval | Type 3 - New Dosage Form | STANDARD |
Label (PDF)
Letter (PDF) Review Summary Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022404lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022404s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022404s000_oravig_toc.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022404Orig1s000SumR.pdf |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
02/04/2020 | SUPPL-5 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022404s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/022404Orig1s005ltr.pdf | |
03/05/2013 | SUPPL-3 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022404s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/022404Orig1s003ltr.pdf | |
04/08/2011 | SUPPL-2 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022404s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022404s002ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
02/04/2020 | SUPPL-5 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022404s005lbl.pdf | |
03/05/2013 | SUPPL-3 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022404s003lbl.pdf | |
04/08/2011 | SUPPL-2 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022404s002lbl.pdf | |
04/16/2010 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022404lbl.pdf |